Opa-Locka, Florida Clinical Trials

A listing of Opa-Locka, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 61 clinical trials
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and progression of clinical symptoms associated with Alzheimer's disease (AD) in participants at the risk to develop clinical symptoms based on their age and genotype.

mini-mental state examination
alzheimer's disease
mental state examination
apolipoprotein e4
University of Miami
 (8.4 away) Contact site
  • 32 views
  • 16 Feb, 2024
  • +126 other locations
Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease

This study is a Phase 3, randomized, double-blind, placebo-controlled study of voxelotor in pediatric participants, aged 2 to < 15 years old, with Sickle Cell Disease. The primary objective is to evaluate the effect of voxelotor on the TCD (Transcranial Doppler Ultrasound) measurements in SCD participants in this age range.

gbt440
anemia
cerebral blood flow
transcranial doppler ultrasonography
pediatric
University of Miami Medical Center
 (8.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +34 other locations
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary arterial hypertension (PAH) compared to macitentan 10 mg.

heart disease
ventricular septal defect
hemodynamic evaluation
right heart catheterization
macitentan 10 mg
University of Miami
 (8.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +210 other locations
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

pneumococcal conjugate
conjugate vaccine
Acevedo Clinical Research Associates
 (6.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +46 other locations
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

The primary objective of this study is to demonstrate the non-inferiority of the vaccine seroresponse to meningococcal serogroups A, C, Y, and W following administration of 2 doses of MenACYW conjugate vaccine compared to 2 doses of MENVEO when given concomitantly with routine pediatric vaccines to infants and toddlers 6 …

Investigational Site Number 8400034
 (3.4 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +46 other locations
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease  

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in participants with Early Parkinson's Disease (PD) who are on stable symptomatic PD medication.

early parkinson's
parkinsonism
bradykinesia
resting tremor
tremor
Aventura Neurologic Associates; Department of Research
 (7.8 away)
  • 0 views
  • 28 Jun, 2022
  • +125 other locations
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

This study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma. The breast cancer in this study is either metastatic (spread into other parts of the body) …

University of Miami
 (8.4 away) Contact site
  • 0 views
  • 14 Mar, 2022
  • +227 other locations
Qa123  

qa1

Test Site 1
 (7.8 away)
  • 0 views
  • 23 Apr, 2024
  • +1 other locations
Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

The pharmacokinetics of a single dose of pexidartinib will be investigated in participants with impaired hepatic function and compared with healthy control participants with normal hepatic function.

Clinical Pharmacology of Miami, LLC.
 (3.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis

This is a phase 1, open label, single arm study in which ARQ-151 cream 0.3% is applied QD for 2 weeks to adolescent subjects with chronic plaque psoriasis involving at least 10% body surface area (BSA) and adult subjects with chronic plaque psoriasis involving at least 20% BSA (excluding scalp). …

12 lead electrocardiogram
psoriasis vulgaris
electrocardiogram
serum pregnancy test
psoriasis
Arcutis Clinical Site 06
 (5.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations